Select Medical Holdings Management
Management criteria checks 1/4
Select Medical Holdings' CEO is David Chernow, appointed in Jan 2014, has a tenure of 10.25 years. total yearly compensation is $10.71M, comprised of 9.3% salary and 90.7% bonuses, including company stock and options. directly owns 0.73% of the company’s shares, worth $25.83M. The average tenure of the management team and the board of directors is 1.1 years and 14.7 years respectively.
Key information
David Chernow
Chief executive officer
US$10.7m
Total compensation
| CEO salary percentage | 9.3% |
| CEO tenure | 10.3yrs |
| CEO ownership | 0.7% |
| Management average tenure | 1.1yrs |
| Board average tenure | 14.7yrs |
Recent management updates
Recent updates
Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely
Apr 19
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down
Apr 11Select Medical: Solid Growth Prospects And A Compelling Valuation
Mar 05Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely
Feb 18We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt
Jan 15Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes
Dec 31Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125
Nov 06Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors
Oct 25What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Oct 04Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?
Sep 16Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold
Aug 11Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125
Aug 07Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward
Jul 14At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?
Jun 29Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
May 27Select Medical: Revising To Hold As Business Economics Roll Lower
May 26Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital
Apr 05Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?
Mar 17Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line
Feb 23Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
Jan 31The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence
Dec 20Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?
Dec 01Select Medical declares $0.125 dividend
Nov 03These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively
Nov 01Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down
Sep 16Select Medical: Adding To Position For Further Upside Capture
Sep 14Calculating The Fair Value Of Select Medical Holdings Corporation (NYSE:SEM)
Aug 31Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125
Aug 10Select Medical down 9% on Q2 profit miss, reiterates full-year forecast
Aug 05Select Medical Holdings (NYSE:SEM) Has A Somewhat Strained Balance Sheet
Jul 31Select Medical: Return Objective Of 26% Justifies Fit In Equity Portfolios
Jul 01Is Now The Time To Put Select Medical Holdings (NYSE:SEM) On Your Watchlist?
Jun 05At US$24.30, Is It Time To Put Select Medical Holdings Corporation (NYSE:SEM) On Your Watch List?
May 22Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of US$0.13
May 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$11m | US$995k | US$235m |
| Sep 30 2023 | n/a | n/a | US$217m |
| Jun 30 2023 | n/a | n/a | US$196m |
| Mar 31 2023 | n/a | n/a | US$174m |
| Dec 31 2022 | US$9m | US$995k | US$153m |
| Sep 30 2022 | n/a | n/a | US$175m |
| Jun 30 2022 | n/a | n/a | US$223m |
| Mar 31 2022 | n/a | n/a | US$329m |
| Dec 31 2021 | US$12m | US$995k | US$389m |
| Sep 30 2021 | n/a | n/a | US$415m |
| Jun 30 2021 | n/a | n/a | US$415m |
| Mar 31 2021 | n/a | n/a | US$306m |
| Dec 31 2020 | US$8m | US$995k | US$250m |
| Sep 30 2020 | n/a | n/a | US$206m |
| Jun 30 2020 | n/a | n/a | US$162m |
| Mar 31 2020 | n/a | n/a | US$155m |
| Dec 31 2019 | US$8m | US$995k | US$143m |
| Sep 30 2019 | n/a | n/a | US$136m |
| Jun 30 2019 | n/a | n/a | US$138m |
| Mar 31 2019 | n/a | n/a | US$140m |
| Dec 31 2018 | US$8m | US$995k | US$133m |
| Sep 30 2018 | n/a | n/a | US$207m |
| Jun 30 2018 | n/a | n/a | US$193m |
| Mar 31 2018 | n/a | n/a | US$189m |
| Dec 31 2017 | US$7m | US$984k | US$171m |
Compensation vs Market: David's total compensation ($USD10.71M) is above average for companies of similar size in the US market ($USD6.59M).
Compensation vs Earnings: David's compensation has increased by more than 20% in the past year.
CEO
David Chernow (66 yo)
10.3yrs
Tenure
US$10,706,265
Compensation
Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.2yrs | US$10.77m | 6.86% $ 241.5m | |
| Chief Executive Officer | 10.3yrs | US$10.71m | 0.73% $ 25.8m | |
| Co-Founder & Vice Chairman | 19.3yrs | US$7.08m | 6.96% $ 244.8m | |
| Executive VP & CFO | less than a year | US$1.53m | 0.098% $ 3.5m | |
| Senior Executive VP | 27.2yrs | US$4.44m | 0.34% $ 12.0m | |
| Senior Executive Vice President of Strategic Finance & Operations | less than a year | US$6.47m | 0.97% $ 34.2m | |
| Co-President | less than a year | no data | 0.48% $ 17.0m | |
| Co-President | less than a year | no data | 0.23% $ 8.1m | |
| Senior VP | 1.1yrs | no data | 0.019% $ 685.4k | |
| Executive VP & Chief Information Officer | 3.3yrs | no data | 0.22% $ 7.8m | |
| Senior Vice President of Compliance & Audit | no data | no data | 0.026% $ 904.2k | |
| Senior VP & Chief Communications | less than a year | no data | no data |
1.1yrs
Average Tenure
54yo
Average Age
Experienced Management: SEM's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.2yrs | US$10.77m | 6.86% $ 241.5m | |
| Co-Founder & Vice Chairman | 19.3yrs | US$7.08m | 6.96% $ 244.8m | |
| Independent Lead Director | 19.2yrs | US$384.40k | 0.85% $ 29.8m | |
| Independent Director | 20.2yrs | US$382.70k | 0.062% $ 2.2m | |
| Independent Director | 4.8yrs | US$405.80k | 0.044% $ 1.5m | |
| Independent Director | 13.9yrs | US$407.83k | 0.21% $ 7.5m | |
| Independent Director | 5.4yrs | US$394.40k | 0.034% $ 1.2m | |
| Independent Director | 15.4yrs | US$414.83k | 0.11% $ 3.8m | |
| Independent Director | 3yrs | US$409.80k | 0.028% $ 986.9k | |
| Independent Director | 2.4yrs | US$407.83k | 0.025% $ 889.8k |
14.7yrs
Average Tenure
65yo
Average Age
Experienced Board: SEM's board of directors are seasoned and experienced ( 14.7 years average tenure).